What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-03-10 compared with 2025-03-14 · 26 added, 15 removed, 22 unchanged (65% of the section changed)

2 unchanged sentences

Our common stock eligible for quotation on the

Pink Market OTC Markets Group Inc.

under the symbol “CDIX.” The following table sets forth, for the periods indicated, the

high and low closing prices of our common stock.

These prices reflect inter-dealer prices, without retain mark-up or commission, and may

not represent actual transactions.

Closing Prices

Fiscal Year Ended December 31, 2023

Fiscal Year Ended December 31, 2024

OTCQB Market operated by OTC Markets Group Inc.

under the symbol “CDIX.” The OTCQB Market is a regulated quotation service

that displays real-time quotes, last sale prices and volume information in over-the-counter securities.

Any over-the-counter market quotations

reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

Number of Holders of Our Common Stock

As of March 12, 2025, there were approximately

909 stockholders of record of our common stock.

In computing the number of holders of record of our common stock, each broker-dealer and

clearing corporation holding shares on behalf of its customers is counted as a single stockholder.

As of March 9, 2026, there were

approximately 995 stockholders of record of our common stock.

In computing the number of holders of record of our common stock, each

broker-dealer and clearing corporation holding shares on behalf of its customers is counted as a single stockholder.

Securities Authorized for Issuance Under Equity

13 unchanged sentences

Recent Sales of Unregistered Securities

We have not sold any equity securities during

the 2024 fiscal year that were not previously disclosed in a quarterly report on Form 10-Q or a current report on Form 8-K that was filed

during the 2024 fiscal year.

Except as set forth below, we have not sold any

equity securities during the 2025 fiscal year that were not previously disclosed in a quarterly report on Form 10-Q or a current report

on Form 8-K that was filed during the 2025 fiscal year.

· On October 31, 2025, we issued a three-year warrant

to purchase 100,000 shares of common stock at an exercise price of $3.00 (subject to adjustments) to a service provider.

· On November 3, 2025, we issued 16,667 shares

of common stock to a service provider.

· On November 19, 2025, we issued an aggregate

of 6,716,728 shares of common stock upon the conversion of an aggregate of 10,075,092 shares of series I preferred stock.

· On November 25, 2025, we issued 30,454 shares

of series N senior convertible preferred stock, 10,698 shares of series X senior convertible preferred stock and 26,114 shares of series

Y senior convertible preferred stock as payment of accrued dividends.

· On November 25, 2025, we issued 100,000 shares

of common stock to a consultant for services rendered.

· See Item 7 “ Management’s Discussion

and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Convertible Notes ”

for a description of certain convertible promissory notes, warrants and shares of common stock issued in December 2025.

Purchases of Equity Securities

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity